logo


Americans Making Tough Choices to Reduce Their Healthcare Costs
Thursday, May 14, 2009 9:19 AM


According to New “Under the Skin” Study from ORC Guideline

As job losses continue across America, concerns about meeting mortgage and credit card payments are only two of the financial issues weighing heavily on the minds of the average American. Almost half (49 percent) of respondents polled in the newly established ‘Under the Skin’ series from ORC Guideline, an infoGROUP company (NASDAQ: IUSA), said they would be unable to afford healthcare coverage if they became unemployed.

Healthcare appeared to be a top priority for respondents, with 85 percent indicating they had seen a doctor in the last 12 months. But while they may be visiting the doctor, many are not following orders. Cost-cutting is widespread, as more than 71 percent of respondents who had seen a doctor in the last 12 months reported taking one or more measures to reduce their medical expenses. Twenty percent said they had delayed a recommended treatment due to cost, 23 percent reported selecting a lower cost option for a recommended test or treatment, and 16 percent said they decided against treatment altogether due to cost.

The study also found that 13 percent of Americans have no health insurance, and the same percentage have had to borrow to pay for existing healthcare bills. As the future of health insurance continues to be discussed in the Oval Office, 58 percent said that the government should be required to pay health insurance for individuals unable to obtain insurance through an employer.

"As this study shows, many Americans are making tough choices with respect to their healthcare in the face of the current recession," said Regine O'Neill, Vice President at ORC Guideline. "The heightened unemployment rate and job insecurity is changing the reality in terms of access to healthcare for both consumers and the providers that serve them. These factors, combined with the increased focus of the current administration on healthcare costs, are likely to mean significant changes to the way healthcare is delivered and paid for in the future."

To help reduce the cost of their healthcare bills, survey respondents pointed to the following measures they reported taking in the last 12 months:

Switched to generic prescriptions             50 %
Avoided going to the doctor when they should have 25 %
Delayed recommended treatments due to cost 18 %
Decided against recommended treatments due to cost 17 %
Took medication less often than prescribed 17 %
Did not fill prescriptions when needed 16 %
Switched to a plan with higher deductibles/co-pays 13 %
Dropped healthcare coverage entirely 7 %
 

About Under the Skin Series
The ‘Under the Skin’ series of studies links ORC Guideline’s expertise in the pharmaceutical and healthcare space to a consumer interest survey. The survey focuses on American’s perceptions of the healthcare system, health insurance coverage, drug choices and wellness.

About ORC Guideline
ORC Guideline is the nation’s premier provider of customized research and analysis designed to help companies make more informed decisions. With an integrated suite of primary research, secondary research, competitive intelligence, and expert insight, we help clients solve their most challenging business issues. Our multi-dimensional approach to research allows us to source, synthesize and analyze data in innovative ways and provide strategic insight to companies across a broad-range of industries.

ORC Guideline is part of Opinion Research Corporation (ORC), a leading global market research firm with offices across the U.S., Europe and Asia Pacific region. The market research industry’s only true global boutique, ORC is a leader in the integration of research and technology, and is known for its nimble, flexible and responsive approach to the complex market research challenges facing its clients. ORC is an official partner of CNN, the most trusted name in news, on the CNN/Opinion Research Corporation Poll. To learn more about Opinion Research Corporation, visit www.opinionresearch.com. To learn more about ORC Guideline, visit www.orcguideline.com.

About infoGROUP
infoGROUP (NASDAQ: IUSA) is the leading provider of data and interactive resources that enables targeted sales, effective marketing and insightful research solutions. Our information powers innovative tools and insight for businesses to efficiently reach current and future customers through multiple channels, including the world’s most dominant and powerful Internet search engines and GPS navigation systems. infoGROUP headquarters are located at 5711 S. 86th Circle, Omaha, NE 68127. For more information, call (402) 593-4500 or visit www.infogroup.com.

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, but are not limited to, recent changes in senior management, the successful integration of recent and future acquisitions, fluctuations in operating results, failure to successfully carry out our Internet strategy or to grow our Internet revenue, effects of leverage, changes in technology and increased competition. More information about potential factors that could affect the company's business and financial results is included in the company's filings with the Securities and Exchange Commission.

For ORC Guideline:
www.orcguideline.com
CAROLYN WERBLER, ORC
Phone: (609) 452-5258
or
CAROLINE HARRIS, CJP COMMUNICATIONS
Phone: (212) 279-3115 ext. 222
or
KELLY LOONTJER, infoGROUP
Director of External Communications
Phone: (402) 596-7574
E-mail: kelly.loontjer@infogroup.com

(Source: Business Wire )


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia